Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 62 announcements

Share price
₹272.05
Market cap
₹3,046 Cr
Revenue (annual)
₹745.8 Cr
Net profit (annual)
₹168.7 Cr
P/E (TTM)
18.4×Sector 47.4×
Promoter holding
43.24%-0.02% QoQ
FII holding
26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:50 IST BSE
Board Meeting Date

Advanced Enzyme Technologies Board Meeting Date

Advanced Enzyme Technologies Ltd scheduled a board meeting for August 08, 2026, to consider Q1 FY27 financial results and a proposal for a share buyback.

18:18 IST NSE
Board Meeting Date

Advanced Enzyme Technologies Board Meeting Date

Advanced Enzyme Technologies Limited has scheduled a Board meeting on May 09, 2026, to approve audited financial results for FY2026 and consider recommending final and interim dividends. The trading window for company securities remains closed until May 11, 2026.

18:12 IST BSE
Board Meeting Date

Advanced Enzyme Technologies Board Meeting Date

Advanced Enzyme Technologies Ltd has scheduled a board meeting on May 09, 2026, to approve FY2026 annual financial statements and recommend dividends. The company also announced that its trading window will remain closed until May 11, 2026.